Moderate

Abnormal uterine bleeding / heavy menstrual bleeding management

HMB · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Heavy menstrual bleeding affecting quality of life is managed by treating underlying structural or non-structural causes (PALM-COEIN framework), with medical options tried before surgery in most women.

Red flags

  • Postmenopausal bleeding
  • Intermenstrual or postcoital bleeding
  • Rapidly enlarging pelvic mass
  • Persistent bleeding despite treatment
  • Symptomatic severe anaemia

Assessment

Differential diagnosis

  • Dysfunctional/ovulatory dysfunction bleeding
  • Fibroids
  • Endometrial polyp
  • Adenomyosis
  • Endometrial hyperplasia or malignancy
  • Coagulopathy (e.g. von Willebrand disease)
  • Hypothyroidism

Investigations

  • FBC for iron deficiency anaemia
  • Pelvic examination and cervical screening if due
  • Transvaginal ultrasound for structural causes
  • Endometrial biopsy if age over 45, risk factors, or treatment failure
  • Coagulation/von Willebrand screen if bleeding since menarche or family history
  • Thyroid function if clinically indicated

Management

  • Take a menstrual and bleeding history and assess impact on quality of life
  • Examine and arrange ultrasound to identify structural causes
  • Correct iron deficiency anaemia
  • Sample the endometrium where malignancy risk is raised
  • Offer the levonorgestrel intrauterine system as first-line medical treatment where appropriate
  • Offer non-hormonal options (tranexamic acid, mefenamic acid) for women wanting to conceive or avoid hormones
  • Offer combined hormonal contraception or oral/long-acting progestogens as alternatives
  • Treat structural causes directly (e.g. polypectomy, myomectomy, uterine artery embolisation)
  • Consider endometrial ablation or hysterectomy if medical therapy fails and family complete

Drugs & doses

Levonorgestrel intrauterine system 52 mg (first-line)
Tranexamic acid 1 g PO three to four times daily during menses
Mefenamic acid 500 mg PO three times daily during menses
Norethisterone 5 mg PO three times daily (days 5-26) for short-term control; combined pill as an option

Disposition

Primary care initiation of medical therapy; refer to gynaecology for structural pathology, treatment failure, or suspected malignancy, and urgently for postmenopausal bleeding.

Complications & pitfalls

  • Iron deficiency anaemia
  • Reduced quality of life
  • Missed endometrial pathology
  • Treatment side effects
  • Recurrence after conservative treatment

Exam pearls

  • The levonorgestrel intrauterine system is the most effective medical treatment and reduces bleeding by about 90%
  • Tranexamic acid and NSAIDs are useful when hormones are unwanted
  • Biopsy the endometrium in women over 45 or with risk factors before ablation
  • Investigate intermenstrual and postcoital bleeding separately as they suggest other pathology

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.